SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Synthetix is a decentralized perpetual futures protocol built on Ethereum Mainnet. Synthetix uses a hybrid design — off-chain order matching on a high-performance CLOB with on-chain settlement — to deliver low latency, deep liquidity, and MEV-resistant execution while keeping custody and finality on Ethereum. Traders get CEX-like performance with on-chain security and composability. The protocol’s liquidity is provided by the Synthetix Liquidity Provider (SLP) vault and backstopped by staked SNX collateral, which underwrites the issuance of the sUSD stablecoin and the solvency of the SLP vault.

Synthetix Network 

Synthetix Network is capturing significant attention due to its upcoming $1 million mainnet perpetuals trading competition and the launch of its V3 perps with multi-collateral support on Ethereum. The community is buzzing about the end of SNX token inflation and the start of buybacks, fueling bullish price speculation and increased trading volume.

Telcoin is a multi-national fintech company  integrating blockchain technology, telecommunications, and digital banking to revolutionize global finance. It aims to provide borderless, instant, and affordable financial services to mobile phone users worldwide. Telcoin offers the Telcoin Wallet, a multi-signature DeFi wallet supporting more than 100 digital assets and remittances to eWallets and bank accounts globally. Telcoin is regulated as a Virtual Asset Service Provider in the EU (Lithuania) and Argentina, a Major Payment Institution in Singapore, and a Money Services Business in the US, Canada, and Australia.   Telcoin is designed to complement telecom, mobile money, and e-wallet partners globally with both traditional fiat and blockchain transaction rails that underpin our fast and affordable digital financial service offerings. Telcoin combines the best parts of the burgeoning DeFi ecosystem with our compliance-focused approach to each market, ensuring that the company takes on a fraction of traditional financial counterparty, execution, and custody risks.  The Telcoin Association is a Swiss non-profit organization domiciled in Lugano, Switzerland and is governed by a decentralized group of Miner Councils that run the various aspects of the Telcoin Platform, including the management of the Telcoin (TEL) token. Read more about the Telcoin Association [here](https://www.telcoin.org).

Telcoin

Telcoin is a hot topic among crypto enthusiasts, who are actively discussing its pioneering role as the first US Digital Asset Bank. The community is eagerly anticipating the launch of its V5 network and eUSD stablecoin, which are seen as pivotal steps in bridging traditional finance with DeFi and driving significant growth.

USDX (Website: usdx.money | Twitter: @StablesLabs) is a synthetic USD stablecoin designed to provide stability without relying on traditional banking infrastructure. Backed by delta-neutral positions across multiple exchanges, USDX seamlessly bridges the gap between DeFi, CeFi, and TradFi. It enables DeFi users to access traditional delta-neutral strategies executed in CeFi platforms. As a crypto-native stablecoin, USDX offers a scalable, censorship-resistant, and highly stable solution for users looking to navigate the world of decentralized finance with confidence.

USDX Stablecoin

USDX Stablecoin is under intense scrutiny after crashing sharply following the Balancer hack, sparking community discussions about the inherent fragility of DeFi stablecoins and broader market concerns over concentrated ownership and regulatory oversight.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

iShares MSCI South Korea ETF (EWY) is trending as it consistently hits new highs, driven by its heavy exposure to the booming semiconductor sector, particularly key players like Samsung and SK Hynix benefiting from surging AI memory demand. The community is actively discussing its significant outperformance against US markets and its appealing valuation in the global landscape.

Helium is a decentralized machine network powered by a physical blockchain. The network is created by gateways who also double as miners on our network. These gateway operators can earn tokens based on coverage they provide as well as transaction fees gained from machines connecting to their gateway  Helium is a new cryptocurrency. Hotspots earn for providing and validating wireless coverage and when devices on the network connect to the internet through Hospots  Helium is mined and distributed to Hotspot Owners, Helium Inc, and investors. There is no pre-mine of Helium, and every month approximately 5,000,000 new Helium are minted.  At the end of each mining period, roughly every 30 to 60 mins, Helium is distributed according to the allocation shown:

Helium

Helium (HNT) is trending after the SEC dismissed its lawsuit and a significant partnership with AT&T emerged, solidifying its role in the DePIN sector. Community sentiment is highly polarized, with strong bullish conviction in its real-world utility and institutional interest contrasting with concerns over project management and token economics for miners.

Comtech Telecommunications Corp. engages in the provision of emergency systems and wireless and satellite communications. It operates through Satellite and Space Communications and Allerium segments. The Satellite and Space Communication segment offers satellite ground station technologies, services and system integration that facilitate the transmission of voice, video, and data over GEO, MEO, and LEO satellite constellations, including solid-state and traveling wave tube power amplifiers, modems, VSAT platforms and frequency converters. The Allerium segment provides emergency call routing, location validation, network, policy-based routing rules, logging and security functionality to states and local governments. The company was founded in 1967 and is headquartered in Chandler, AZ.

Comtech Telecommunications Corp.

Comtech Telecommunications is gaining attention as a potential turnaround story under new CEO Ken Traub, driven by recent strategic financing efforts, major contract wins in 911 services and satellite solutions, and active speculation regarding a high-value divestiture of its Terrestrial and Wireless segment. The community is also closely watching its emerging partnership with Quantum Computing Inc. for quantum satellite communications, poised to unlock substantial long-term value.

ACM Research, Inc. engages in the development, manufacture, and sale of single-wafer wet cleaning equipment. It supplies process solutions that semiconductor manufacturers can use in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield. The company tools can be used in fabricating foundry, logic and memory chips including dynamic random-access memory, or DRAM, and 3D NAND-flash memory chips. The company was founded by David H. Wang and Hui Wang in January 1998 and is headquartered in Fremont, CA.

ACM Research Inc - Ordinary Shares - Class A

ACM Research is trending following a bullish report from Kerrisdale Capital, which highlights the company's severe undervaluation compared to its Shanghai subsidiary and strong position in the growing semiconductor equipment market. The community is actively debating the stock's long-term potential fueled by expansion and robust fundamentals against persistent concerns over volatility and the impact of its significant China exposure.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech is experiencing a strong rally following its significant beat on Q1 earnings and raised full-year guidance. This stellar performance is igniting community discussion around a potential short squeeze, given the company's high short interest and its position as an innovative AI-driven leader in the beauty-tech sector.

The New York Times Co. is a media organization, which engages in creating, collecting, and distributing news and information. It offers news products and other interest-specific products, and related content and services. It offers newspapers, print, and digital products and investments. The firm also manages The New York Times, NYTimes.com, and mobile applications. The company was founded by Henry Jarvis Raymond and George Jones on September 18, 1851, and is headquartered in New York, NY.

New York Times Co. - Ordinary Shares - Class A

The New York Times is trending as Berkshire Hathaway's new stake ignites community debate on the value of trusted content in the AI era, further fueled by the company's strong digital subscription growth and aggressive stance against AI firms for unauthorized content use.

Mondelez International, Inc. engages in the manufacture and marketing of snack food and beverage products. Its products include beverages, biscuits, chocolate, gum and candy, cheese and groceries, and meals. Its brands include 5Star, 7Days, Alpen Gold, Barni, Belvita, Bournvita, Cadbury, Cadbury Dairy Milk, Chips Ahoy! Clif, Clorets, Club Social, Côte d'Or, Daim, Enjoy Life Foods, Freia, Grenade, Halls, Honey Maid, Hu, Kinh Do, Lacta, Lu, Marabou, Maynards Bassett’s, Mikado, Milka, Oreo, Perfect Snacks, Philadelphia, Prince, Ritz, Royal, Sour Patch Kids, Stride, Tang, Tate’s Bake Shop, Tiger, Toblerone, Triscuit, TUC, and Wheat Thins. It operates through the following geographical segments: Latin America, Asia, Middle East, and Africa, Europe, and North America. The company was founded by James Lewis Kraft in 1903 is headquartered in Chicago, IL.

Mondelez International Inc. - Ordinary Shares - Class A

Mondelez is trending after exceeding recent earnings estimates, as investors debate whether muted 2026 guidance will overshadow the anticipated boost to future margins from dramatically falling cocoa prices, amidst ongoing discussions about consumer behavior and production strategies.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bluebird Bio (BLUE) Reports Q1 Loss, Lags Revenue Estimates

Bluebird Bio, Inc. (BLUE) said on Wednesday that global investment firms Carlyle (CG) and SK Capital Partners have agreed to purchase all its outstanding shares and take the company private for $5 per share upfront.Under the terms of the <a target="_blank" rel="noopener noreferrer nofollow" href="https://investor.bluebirdbio.com/news-releases/news-release-details/carlyle-sk-capital-partners-and-bluebird-bio-amend-merger">amended</a> agreement, Bluebird stockholders can elect to receive either $3 per share in cash plus a contingent value right (CVR) of $6.84 per share in cash payable upon achievement of a net sales milestone or $5 per share in cash.The upfront payment of $5 represents a 51% premium to Bluebird’s closing price of $3.31 on Tuesday.Shares of the company traded over 50% higher on Wednesday morning.Gene therapy maker Bluebird first entered a definitive agreement with Carlyle and SK Capital in February. As per the original agreement, stockholders had only one option of receiving $3.00 per share in cash plus a CVR of $6.84 per share.Bluebird said the amended agreement allows an alternative for stockholders who would prefer greater upfront cash consideration instead of the potential upside of the CVR.The Bluebird board of directors recommended that shareholders tender their shares in support of the transaction by 11:59 p.m., New York City time, on May 29, 2025, following which the tender offer would expire.The company said that unless a majority of stockholders tender their shares, Bluebird is at significant risk of defaulting on its loan agreements with Hercules Capital, and it is extremely unlikely that stockholders would receive any consideration for their shares in a bankruptcy or liquidation.On Stocktwits, retail sentiment around Bluebird rose within the ‘bullish’ territory while message volume jumped from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:633/60;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_14_at_10_22_02_AM_png_1451c7b7eb.webp" alt="BLUE's Sentiment Meter and Message Volume as of 10:20 a.m. ET on May 14, 2025 | Source: Stocktwits" width="633" height="60"><figcaption>BLUE's Sentiment Meter and Message Volume as of 10:20 a.m. ET on May 14, 2025 | Source: Stocktwits</figcaption></figure> <a href="https://stocktwits.com/symbol/BLUE">BLUE stock</a> is down by about 43% this year and about 77% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dynatrace-technology-q4-2025-earnings/chiqru4RbNS">Dynatrace Stock Rises On Upbeat Q4 Earnings, Retail Turns Extremely Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Bluebird bio logo is seen on a smartphone and a pc screen in the background. (Photo Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images)

Bluebird Bio Stock Soars On Higher Upfront Payment Under Amended Merger Deal: Retail Gets More Bullish 

The upfront payment of $5 represents a 51% premium to Bluebird’s closing price of $3.31 on Tuesday.

Equity

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. The company was founded by Philippe Leboulch and Ronald C. Dorazio on April 16, 1992 and is headquartered in Somerville, MA.

BLUE
Bluebird bio Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BLUE News

BLUEBluebird bio Inc